Neuronal injury biomarkers are not dependent on ?-amyloid in normal elderly, Ann. Neurol ,
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, The Lancet Neurology, vol.9, issue.1, pp.119-128, 2010. ,
DOI : 10.1016/S1474-4422(09)70299-6
Toward defining the preclinical stages of Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.280-292, 2011. ,
DOI : 10.1016/j.jalz.2011.03.003
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease, Annals of Neurology, vol.290, issue.pt 8, pp.765-775, 2012. ,
DOI : 10.1002/ana.22628
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease, Neurology, vol.78, issue.20, pp.1576-1582, 2012. ,
DOI : 10.1212/WNL.0b013e3182563bbe
Apolipoprotein E, Not Fibrillar ??-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging, Journal of Neuroscience, vol.32, issue.50, pp.18227-18233, 2012. ,
DOI : 10.1523/JNEUROSCI.3266-12.2012
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study, The Lancet Neurology, vol.11, issue.12, pp.1048-1056, 2012. ,
DOI : 10.1016/S1474-4422(12)70228-4
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease, New England Journal of Medicine, vol.367, issue.9, pp.795-804, 2012. ,
DOI : 10.1056/NEJMoa1202753
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease, Brain, vol.131, issue.1, pp.60-71, 2008. ,
DOI : 10.1093/brain/awm288
Region-Specific Hierarchy between Atrophy, Hypometabolism, and ??-Amyloid (A??) Load in Alzheimer's Disease Dementia, Journal of Neuroscience, vol.32, issue.46, pp.16265-16273, 2012. ,
DOI : 10.1523/JNEUROSCI.2170-12.2012